| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| ClinicalTrials.gov Identifier: | NCT00068900 |
Purpose
We will give intravenous fat molecules to help us understand how the fat that is released from peoples fat cells is used. This will be done when people are eating, not eating and walking.
| Condition |
|
Obesity |
| MedlinePlus related topics: | Obesity |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | FFA Metabolism in Different Types of Human Obesity |
Eligibility
| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria: BMI 28-36 -upper body obesity and lower body obesity non-obese BMI 19-24. Females premenopausal. Must be a non-smoker.
Exclusion Criteria: BP> 160/95 on HTN meds, known systemic illness. Medications that affect fat metabolism. We do no cover travel expenses. Known heart and vascular disease.
Contacts and Locations More Information
| Study ID Numbers: | FFAMET - dk40484 |
| First Received: | September 10, 2003 |
| Last Updated: | June 19, 2008 |
| ClinicalTrials.gov Identifier: | NCT00068900 |
| Health Authority: | United States: Federal Government |
|
|
|
